Royce & Associates LP Insmed Inc Transaction History
Royce & Associates LP
- $10.3 Billion
- Q4 2024
A detailed history of Royce & Associates LP transactions in Insmed Inc stock. As of the latest transaction made, Royce & Associates LP holds 90,027 shares of INSM stock, worth $7.12 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
90,027
Previous 95,027
5.26%
Holding current value
$7.12 Million
Previous $6.94 Million
10.4%
% of portfolio
0.06%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding INSM
# of Institutions
497Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.44 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.13 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$1.02 Billion84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$1 Billion0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$563 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.7B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...